GB1368201A - Treatment of diseases of the skin and mucosa - Google Patents

Treatment of diseases of the skin and mucosa

Info

Publication number
GB1368201A
GB1368201A GB310772A GB310772A GB1368201A GB 1368201 A GB1368201 A GB 1368201A GB 310772 A GB310772 A GB 310772A GB 310772 A GB310772 A GB 310772A GB 1368201 A GB1368201 A GB 1368201A
Authority
GB
United Kingdom
Prior art keywords
mucosa
diseases
skin
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB310772A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COMPREHENSIVE PHARMACEUTICALS
Original Assignee
COMPREHENSIVE PHARMACEUTICALS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COMPREHENSIVE PHARMACEUTICALS filed Critical COMPREHENSIVE PHARMACEUTICALS
Publication of GB1368201A publication Critical patent/GB1368201A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB310772A 1971-01-22 1972-01-21 Treatment of diseases of the skin and mucosa Expired GB1368201A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10901771A 1971-01-22 1971-01-22

Publications (1)

Publication Number Publication Date
GB1368201A true GB1368201A (en) 1974-09-25

Family

ID=22325363

Family Applications (1)

Application Number Title Priority Date Filing Date
GB310772A Expired GB1368201A (en) 1971-01-22 1972-01-21 Treatment of diseases of the skin and mucosa

Country Status (8)

Country Link
AU (1) AU458386B2 (fr)
BE (1) BE778334A (fr)
CA (1) CA963388A (fr)
DE (1) DE2202964A1 (fr)
FR (1) FR2122613B2 (fr)
GB (1) GB1368201A (fr)
IE (1) IE35991B1 (fr)
ZA (1) ZA72423B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002148A1 (fr) * 1992-07-22 1994-02-03 Vepex Kft. Nouvelles compositions biologiquement actives, leur preparation et leur application
EP4014962A1 (fr) * 2020-12-16 2022-06-22 Novigo GmbH & Co. KG Composition comprenant une substance à action osmotique et utilisation de la composition

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59002748D1 (de) * 1990-01-29 1993-10-21 Wogepharm Gmbh Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
DE59409543D1 (de) * 1993-04-02 2000-11-09 Wogerpharm Gmbh Verwendung von wasserlöslichen magnesiumsalzen und äusserlich anzuwendende zubereitungen
EP0801554B1 (fr) 1994-12-21 2003-04-16 Cosmederm Technologies Formulations et procedes pour diminuer l'irritation de la peau
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
AU4606496A (en) * 1994-12-21 1996-07-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
FR2732600B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique et/ou dermatologique et composition obtenue
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
FR2732602B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique ou pharmaceutique pour traiter les prurits
FR2732601B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene
FR2732599B1 (fr) * 1995-04-10 1997-05-16 Oreal Utilisation de sels de metaux alcalino-terreux comme inhibiteurs de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002148A1 (fr) * 1992-07-22 1994-02-03 Vepex Kft. Nouvelles compositions biologiquement actives, leur preparation et leur application
EP4014962A1 (fr) * 2020-12-16 2022-06-22 Novigo GmbH & Co. KG Composition comprenant une substance à action osmotique et utilisation de la composition
WO2022129425A1 (fr) * 2020-12-16 2022-06-23 Novigo GmbH & Co. KG Composition contenant une substance osmotique et utilisation de la composition

Also Published As

Publication number Publication date
IE35991L (en) 1972-07-22
AU458386B2 (en) 1975-02-10
AU3824272A (en) 1973-07-26
BE778334A (fr) 1972-05-16
DE2202964A1 (de) 1972-08-10
ZA72423B (en) 1972-10-25
FR2122613A2 (fr) 1972-09-01
IE35991B1 (en) 1976-07-21
FR2122613B2 (fr) 1975-08-01
CA963388A (en) 1975-02-25

Similar Documents

Publication Publication Date Title
PH15692A (en) Composition for the treatment of the hair and scalp
ZA731496B (en) Methods and formulations for the treatment of obesity
BR7202329D0 (pt) Composicoes de tratamento tecidos e cosmeticos
GB1368201A (en) Treatment of diseases of the skin and mucosa
IL37098A0 (en) Skin treatment composition and its preparation
MY7500107A (en) Treatment of rubber
GB1374159A (en) Purification of human blood
AU4960072A (en) Treatment of human hair
ZM17172A1 (en) Treatment of titanium
ZA714176B (en) Prophylaxis and treatment of cardiac disorders
IL42108A (en) The preparation of human acth and its fragments
ZA714113B (en) Prophylaxis and treatment of cardiac disorders
AU458749B2 (en) Process for the treatment and care of dentures
AU452550B2 (en) The use of diphenylsulfones inthe treatment of mareks disease
ZA714115B (en) Prophylaxis and treatment of cardiac disorders
ZA724296B (en) New medicants for the treatment of excess lipidic and cellulitic stresses
HK55976A (en) Manufacture and treatment of an inflatable baby's bath
CS183673B2 (en) Sterilizer of objects and medical instrulments
ZA714116B (en) Prophylaxis and treatment of cardiac disorders
CA837050A (en) Method of and composition for the treatment of human carcinoma and hypercholestrolemia
CA919686A (en) Prophylaxis and treatment of cardiac disorders
ZA714175B (en) Prophylaxis and treatment of cardiac disorders
ZA714112B (en) Prophylaxis and treatment of cardiac disorders
AU3771772A (en) Combination of l-dops and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson's disease
AU423068B2 (en) Prophylaxis and treatment of cardiac disorders

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees
PLNP Patent lapsed through nonpayment of renewal fees

Free format text: DELETE FROM JOURNAL 4618,PAGE 2702

PE20 Patent expired after termination of 20 years